Aug 12, 2020
Sinopsys Announces Issuance of European Patent Covering its Novel Stent for the Delivery of Dexamethasone and other Therapeutics to Key Sinus Anatomy
Jun 17, 2020
Emgality® Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine
Jun 15, 2020
AbbVie to Showcase 27 Studies at the Virtual 2020 Annual Scientific Meeting of the American Headache Society
Jun 08, 2020
Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients
May 26, 2020
Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
Apr 22, 2020
Global Sinusitis Pipeline Insights, H1 2020: Provides Data for Therapeutics Under Development by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type
Mar 20, 2020
Dr. Amir HagShenas Offers Painless Tooth Extraction to Alleviate Tooth Pain in San Jose, CA
Mar 11, 2020
Allergy Partners Discusses When a Sinus Infection is More Than "Just" a Sinus Infection?
Jan 08, 2020
GNO Snoring and Sinus Offers New Laboratory Test for Chronic Sinusitis
Dec 18, 2019
Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality® (galcanezumab-gnlm)
Aug 08, 2019
Lilly Announces Positive Results for Emgality(TM) (galcanezumab) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Aug 06, 2019
Sinusleeve(TM) Balloon Device Completes FDA Listing, Dalent Medical Begins Sales In South Florida
Aug 05, 2019
Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
Jul 24, 2019
Manchester, CT Oral Surgeons Relieve Wisdom Tooth Pain with Opioid-Free Treatment
Jul 23, 2019
Theranica: New Publication Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications
Jul 19, 2019
Clearwater, FL Dentists Help Patients Diagnose Toothaches and Relieve Pain with Root Canals
Jul 12, 2019
AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine
Jul 11, 2019
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache
Jun 25, 2019
Global Leaders in Migraine Research to Convene at The American Headache Society 61st Annual Scientific Meeting
Jun 25, 2019
The global sinusitis drugs market size at a CAGR of over 6% during the forecast period